International Patent: ANTIBODY-DRUG CONJUGATE TARGETING EGFR AND CMET AND USE THEREOF

GENEVA, Oct. 5 -- GENCONJERA MEDICINE (SUZHOU) CO., LTD. filed a patent application (CN2026/085654) for “ANTIBODY-DRUG CONJUGATE TARGETING EGFR AND CMET AND USE THEREOF”. With publication no. WO/2026/200927, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: A61K 47/68

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....